The beneficial regulation of Akt-BAD signaling was demonstrated in a previous report in which Notch-2 agonistic monoclonal antibody ameliorated protein leakage and glomerulosclerosis in ADR-induced FSGS mice via regulating Akt-BAD axis36. Here, BAD is linked to glomerulosclerosis.